# FRINDOVYX
> **NDA210852** · New Drug Application · Sponsor: AVYXA HOLDINGS · Approved 2023-06-07
## Drug
- **FDA Application Number:** NDA210852
- **Application type:** New Drug Application
- **Brand name:** FRINDOVYX
- **Generic name:** CYCLOPHOSPHAMIDE
- **Active ingredients:** CYCLOPHOSPHAMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AVYXA HOLDINGS
- **Manufacturer:** Avyxa Pharma, LLC
- **First approval:** 2023-06-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210852)
---
*AI Analytics · CC0 1.0*